CVS Health Co. (NYSE:CVS - Free Report) - Research analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of CVS Health in a research note issued to investors on Monday, June 9th. Cantor Fitzgerald analyst S. James expects that the pharmacy operator will post earnings of $6.82 per share for the year. The consensus estimate for CVS Health's current full-year earnings is $5.89 per share.
CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The company had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. During the same period in the prior year, the firm earned $1.31 earnings per share. CVS Health's revenue for the quarter was up 7.0% on a year-over-year basis.
A number of other research firms also recently issued reports on CVS. Mizuho lifted their price target on CVS Health from $70.00 to $76.00 and gave the company an "outperform" rating in a research note on Wednesday, April 9th. JPMorgan Chase & Co. lifted their target price on CVS Health from $80.00 to $81.00 and gave the company an "overweight" rating in a research report on Tuesday, February 18th. UBS Group upped their price target on CVS Health from $67.00 to $71.00 and gave the stock a "neutral" rating in a report on Friday, May 2nd. Piper Sandler raised their price objective on CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research note on Friday, March 21st. Finally, Leerink Partners raised shares of CVS Health from a "market perform" rating to an "outperform" rating and lifted their target price for the stock from $55.00 to $75.00 in a research report on Thursday, February 13th. Two investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $74.75.
Check Out Our Latest Report on CVS Health
CVS Health Stock Up 1.6%
Shares of NYSE:CVS traded up $1.07 during midday trading on Tuesday, hitting $67.42. 7,560,954 shares of the company's stock were exchanged, compared to its average volume of 10,981,592. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. CVS Health has a 12 month low of $43.56 and a 12 month high of $72.51. The company has a market cap of $85.29 billion, a PE ratio of 18.42, a price-to-earnings-growth ratio of 0.98 and a beta of 0.56. The stock has a 50 day moving average price of $65.15 and a 200-day moving average price of $60.15.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of CVS. Bell Investment Advisors Inc boosted its holdings in shares of CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator's stock worth $31,000 after acquiring an additional 248 shares during the period. Saudi Central Bank purchased a new stake in CVS Health during the 1st quarter worth about $34,000. Costello Asset Management INC boosted its stake in CVS Health by 281.3% in the 1st quarter. Costello Asset Management INC now owns 572 shares of the pharmacy operator's stock worth $39,000 after purchasing an additional 422 shares during the period. Stone House Investment Management LLC purchased a new position in CVS Health during the 1st quarter valued at about $39,000. Finally, Stonebridge Financial Group LLC bought a new stake in shares of CVS Health during the fourth quarter valued at about $28,000. 80.66% of the stock is owned by institutional investors.
Insider Buying and Selling at CVS Health
In other CVS Health news, Director Guy P. Sansone bought 1,570 shares of CVS Health stock in a transaction dated Thursday, June 5th. The stock was purchased at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the completion of the purchase, the director now directly owns 12,007 shares of the company's stock, valued at approximately $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Corporate insiders own 1.22% of the company's stock.
CVS Health Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 3.95%. The ex-dividend date was Tuesday, April 22nd. CVS Health's dividend payout ratio is currently 63.48%.
About CVS Health
(
Get Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Articles
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
